These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10146360)

  • 1. Will new therapy for genetic disease alter underwriting practices?
    Desnick R
    J Insur Med; 1993; Suppl B():247-51. PubMed ID: 10146360
    [No Abstract]   [Full Text] [Related]  

  • 2. How will improved forecasts of individual lifetimes affect underwriting?
    MacDonald AS
    Philos Trans R Soc Lond B Biol Sci; 1997 Aug; 352(1357):1067-75. PubMed ID: 9304673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic revolution.
    Elmer-Dewitt P
    Time; 1994 Jan; 143(3):46-53. PubMed ID: 11645248
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic testing in insurance underwriting: a blessing or a curse? An examination of the tension between economics and equity in using genetic testing in risk classification.
    Anderson MC
    Creighton Law Rev; 1992 Jun; 25(4):1499-535. PubMed ID: 11654461
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural aspects of therapeutic enzymes to treat metabolic disorders.
    Kang TS; Stevens RC
    Hum Mutat; 2009 Dec; 30(12):1591-610. PubMed ID: 19790257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New genetics means no new ethics.
    Maddox J
    Nature; 1993 Jul; 364(6443):97. PubMed ID: 11659611
    [No Abstract]   [Full Text] [Related]  

  • 7. [The advances of gene therapy in this quarter century].
    Ito Y; Niitsu Y
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():51-9. PubMed ID: 10410659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underwriting lethal genetic diseases.
    Lowden JA
    J Insur Med; 1998; 30(1):5-11. PubMed ID: 10186441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eric S. Lander.
    Lander ES
    Nat Rev Drug Discov; 2004 Sep; 3(9):730. PubMed ID: 15368656
    [No Abstract]   [Full Text] [Related]  

  • 10. New frontiers in hereditary metabolic disease: an historical perspective.
    Cederbaum SD
    Mol Genet Metab; 2006 Mar; 87(3):184-9. PubMed ID: 16403665
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy progress and prospects: fetal gene therapy--first proofs of concept--some adverse effects.
    Coutelle C; Themis M; Waddington SN; Buckley SM; Gregory LG; Nivsarkar MS; David AL; Peebles D; Weisz B; Rodeck C
    Gene Ther; 2005 Nov; 12(22):1601-7. PubMed ID: 16136161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of DNA into muscle for treating systemic diseases: advantages and challenges.
    Trollet C; Scherman D; Bigey P
    Methods Mol Biol; 2008; 423():199-214. PubMed ID: 18370200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of genetic information by private insurers. Genetic advances: the perspective of an insurance medical director.
    Pokorski RJ
    J Insur Med; 1992; 24(1):60-8. PubMed ID: 10148476
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy. Repair kits for faulty genes.
    Ferber D
    Science; 2001 Nov; 294(5547):1639. PubMed ID: 11721030
    [No Abstract]   [Full Text] [Related]  

  • 16. Do you have a cancer gene?
    Rubin R
    US News World Rep; 1996 May; 120(19):67-68, 70, 73-74, 77. PubMed ID: 11645319
    [No Abstract]   [Full Text] [Related]  

  • 17. Underwriting dominantly inherited diseases.
    Lowden JA
    J Insur Med; 1995-1996 Winter; 27(3):228-34. PubMed ID: 10160224
    [No Abstract]   [Full Text] [Related]  

  • 18. Rerun of German genetic therapy.
    Med World News; 1975 Aug; 16(18):30-1. PubMed ID: 11662968
    [No Abstract]   [Full Text] [Related]  

  • 19. Genome medicine: gene therapy for the millennium, 30 September-3 October 2001, Rome, Italy.
    Gruenert DC; Novelli G; Dallapiccola B; Colosimo A
    Gene Ther; 2002 Jun; 9(11):653-7. PubMed ID: 12032680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is genetic information relevantly different from other kinds of non-genetic information in the life insurance context?
    Malpas PJ
    J Med Ethics; 2008 Jul; 34(7):548-51. PubMed ID: 18591292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.